JPMorgan Chase & Co. Acquires 124,246 Shares of Illumina, Inc. $ILMN

Clinical OMICsOLE Identified as a Potential Alzheimer’s Therapy Targeting Microglia

Endpoints NewsFDA gives rejected drugs another chance in post-Makary era

Clinical OMICsAI Discovers Two New Antibiotics for Drug-Resistant Gonorrhea

Clinical OMICsGLP-1 Drugs Reduce Crime-Linked Behavior

Clinical OMICsMacrophage EGFR Activity Linked to Immune Suppression, Tumor Growth in Colorectal Cancer

Clinical OMICsUnexpected Role for RNA Editing in Cancer Immune Evasion Uncovered

Clinical OMICsProactive Surveillance Pays Off for Patients with Li-Fraumeni Syndrome

Clinical OMICsCAR T Success Hinges on Microenvironment Response in GBM

Endpoints NewsFDA warns telehealth companies over compounded GLP-1s

BioPharma DiveUniQure to file gene therapy for approval, reflecting major shifts at FDA

BioWorldEdgewise heads to phase III with solid EDG-7500 data in HCM

Endpoints NewsUK waitlist for Novo's Wegovy pill triples in week after approval, major online pharmacy says